The coordinated elevation of CXCL9, CXCL10 and CCL19 in acute Lyme disease is consistent with an ongoing host immune response in the draining lymph nodes accompanied by the generation of Borrelia - reactive effector T cells and their migration into the site of infection. This evidence concerns the gene CCL19 and infection.